Eye therapy company raises £4.8m to boost overseas expansion
NuVision Biotherapies, a spin-out whose products speed up healing of eye conditions, has raised a further £4.8m in a funding round led by the Midlands Engine Investment Fund II through its appointed fund manager Mercia Ventures, and including the University of Nottingham and Pioneer Group. NuVision’s products harness amniotic membrane, the tissue that surrounds babies